Toomas Sorra, MD
Gastroenterology · Brooklyn, NYNPI 1679550669
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,821 of the $2,036 with a category attached, or 89.4%. Olympus America Inc. accounts for 89.4% of it on its own, with 6 other manufacturers making up the rest. That places this record below the midpoint for gastroenterology clinicians in NY, where the typical reported total is $1,827.
Across 13 payments — averaging $156.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$2K
- Johnson & Johnson$92
- Braintree Laboratories, Inc.$43
- Bristol Myers Squibb$31
- Merck$19
- Redhill Biopharma Inc.$16
- plus $15 from 1 others
What the payments were for
- Food & beverage$21511%
- Other$1,82189%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 2 | $1,821 |
| Johnson & Johnson | 4 | $92 |
| Braintree Laboratories, Inc. | 2 | $43 |
| Bristol Myers Squibb | 2 | $31 |
| Merck | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$2,036 in reported general payments places this provider in the 50th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 13 | $4,276 |
| Omeprazole | 79 | $897 |
| Losartan Potassium | 41 | $756 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 54 | $645 |
| Amlodipine Besylate | 71 | $641 |
| Rosuvastatin Calcium | 24 | $578 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 19 | $534 |
| Metoprolol Succinate | 22 | $430 |
| Enalapril Maleate | 15 | $287 |
| Procto-Med HcHydrocortisone | 19 | $233 |
| Esomeprazole Magnesium | 16 | $220 |
| Atorvastatin Calcium | 13 | $178 |
| Dicyclomine Hcl | 16 | $175 |
| Famotidine | 17 | $165 |
| Simvastatin | 12 | $134 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Brooklyn
- Sam MoskowitzBrooklyn$332K
- Jianjun LiBrooklyn$211K
- Nison BadalovBrooklyn$200K
- Kevin TinBrooklyn$168K
- Jonathan ErberBrooklyn$164K
- Rabin RahmaniBrooklyn$155K
- Kayane Hanna-HindyBrooklyn$151K
- Kadirawelpillai IswaraBrooklyn$148K
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.